Your browser doesn't support javascript.
loading
GPRC5D as a novel immunotherapeutic target in multiple myeloma.
Nath, Karthik; Costa, Bruno A; Mailankody, Sham.
Affiliation
  • Nath K; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Costa BA; Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Mailankody S; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mailanks@mskcc.org.
Nat Rev Clin Oncol ; 20(5): 281-282, 2023 05.
Article in En | MEDLINE | ID: mdl-36725915

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Estados Unidos